Dental management of patients taking novel oral anticoagulants (NOAs): Dabigatran

BACKGROUND: A new group of oral anticoagulants (dabigatran, rivaroxaban, apixaban and edoxaban) with clear advantages over classic dicoumarin oral anticoagulants (warfarin and acenocoumarol) has been developed in recent years. Patients being treated with oral anticoagulants are at higher risk for bl...

Descripción completa

Detalles Bibliográficos
Autores principales: Curto, Adrian, Albaladejo, Alberto, Alvarado, Alfonso
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medicina Oral S.L. 2017
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5303333/
https://www.ncbi.nlm.nih.gov/pubmed/28210451
http://dx.doi.org/10.4317/jced.53219

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5303333/
https://www.ncbi.nlm.nih.gov/pubmed/28210451
http://dx.doi.org/10.4317/jced.53219

Ejemplares similares